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Clinical PerspectiveWhat Is New?This is one of the largest population‐based studies to evaluate the characteristics, prevalence, awareness, and treatment patterns of individuals with isolated diastolic hypertension (IDH) in China, allowing us to draw robust conclusions across diverse subgroups.We found that IDH affected a large number of adults in China, and these patients had some unique characteristics as compared with people without hypertension as well as those with other types of hypertension.Awareness of hypertension was significantly lower among people with IDH as compared with other types of hypertension, and most participants with IDH despite treatment had scope for further intensification of therapy.What Are the Clinical Implications?Given that diastolic hypertension can independently influence the risk of adverse cardiovascular events, identifying characteristics that may be associated with IDH and understanding the current awareness and treatment patterns among those with IDH can help identify the patients at increased cardiovascular risk and highlight opportunities to improve their care.Focusing on people with IDH and improving their diagnosis and treatment, may be critical to mitigate the burden of hypertension, especially in the young‐ and middle‐aged population.

Introduction {#jah34457-sec-0008}
============

Isolated diastolic hypertension (IDH), whether in treated or untreated patients, is an uncommon type of hypertension accounting for \<20% of hypertension cases.[1](#jah34457-bib-0001){ref-type="ref"}, [2](#jah34457-bib-0002){ref-type="ref"}, [3](#jah34457-bib-0003){ref-type="ref"}, [4](#jah34457-bib-0004){ref-type="ref"} Nevertheless, IDH is independently associated with an increased risk of stroke, heart disease, and the other sequelae of hypertension.[5](#jah34457-bib-0005){ref-type="ref"}, [6](#jah34457-bib-0006){ref-type="ref"}, [7](#jah34457-bib-0007){ref-type="ref"}, [8](#jah34457-bib-0008){ref-type="ref"}, [9](#jah34457-bib-0009){ref-type="ref"}, [10](#jah34457-bib-0010){ref-type="ref"}, [11](#jah34457-bib-0011){ref-type="ref"}, [12](#jah34457-bib-0012){ref-type="ref"}, [13](#jah34457-bib-0013){ref-type="ref"}, [14](#jah34457-bib-0014){ref-type="ref"} However, the most recent US, Chinese, and European high blood pressure guidelines do not specifically address IDH as a distinct phenotype or provide any specific guidance for its management.[15](#jah34457-bib-0015){ref-type="ref"}, [16](#jah34457-bib-0016){ref-type="ref"}, [17](#jah34457-bib-0017){ref-type="ref"}

Although many studies have focused on patient characteristics, knowledge, and treatment, patients with IDH constitute a small subset of all patients with hypertension, and have traditionally been included within the total population of hypertensive patients,[1](#jah34457-bib-0001){ref-type="ref"}, [18](#jah34457-bib-0018){ref-type="ref"}, [19](#jah34457-bib-0019){ref-type="ref"}, [20](#jah34457-bib-0020){ref-type="ref"} even though they may have unique features.[20](#jah34457-bib-0020){ref-type="ref"}, [21](#jah34457-bib-0021){ref-type="ref"} Given its low prevalence, a large sample size would be required to fully capture the range of attributes of individuals with IDH across diverse population subgroups, and draw robust conclusions with high precision. Characterizing these patients specifically and assessing their awareness and treatment patterns can generate new knowledge about this distinct subtype of hypertension. This information will not only expand our knowledge about the IDH phenotype, but could also equip us to identify targets for improvement of care.

Accordingly, we sought to identify and study patients with IDH, whether treated or untreated, using data from the China PEACE (Patient‐centered Evaluative Assessment of Cardiac Events) Million Persons Project, a large‐scale population‐based screening project which was initiated with the aim of providing detailed information on smaller subgroups of patients who have traditionally been hard to identify in the population. We sought to describe the characteristics and prevalence of individuals with IDH across diverse population subgroups among both untreated and treated hypertensives; assess awareness of having hypertension among untreated IDH participants; assess the number and classes of medications used by treated participants with IDH; and identify the associations between individual characteristics with prevalence of, and awareness among those with IDH. Although some of the treated patients may be individuals who initially had systolic and diastolic hypertension, but with medications have only diastolic hypertension, this does represent the spectrum of patients who would be seen in practice with IDH, either as a de novo condition or as inadequately treated diastolic hypertension. Moreover, the treatment rates in China are sufficiently low that the population with IDH largely represents those with the de novo condition.

Methods {#jah34457-sec-0009}
=======

The China PEACE Million Persons Project is a major national program, and as the government policy stipulates, it is not permissible for the researchers to make the raw data publicly available at this time.

Study Design and Population {#jah34457-sec-0010}
---------------------------

Details of the China PEACE Million Persons Project have been described previously.[22](#jah34457-bib-0022){ref-type="ref"}, [23](#jah34457-bib-0023){ref-type="ref"} Briefly, we used a convenience sampling strategy to select 184 sites (111 rural counties and 73 urban districts) from all 31 provinces in mainland China. People were encouraged to participate in the project through publicity campaigns in the newspaper and on the television. Of the 2 351 035 participants aged 35 to 75 years enrolled at these sites between September 15, 2014 and May 29, 2018, we excluded 14 904 participants because of missing or extreme blood pressure values (systolic blood pressure \[SBP\] \<70 or \>270 mm Hg; diastolic blood pressure \[DBP\] \<30 or \>150 mm Hg), 142 participants due to missing or extreme body mass index values (\<10 or \>50 kg/m^2^), and 25 805 participants due to missing data on covariates, including geographical region, education, occupation, marital status, household income, and alcohol use (Figure [S1](#jah34457-sup-0001){ref-type="supplementary-material"}).

Blood Pressure Collection and Classification {#jah34457-sec-0011}
--------------------------------------------

For every participant, blood pressure was measured twice at enrollment, at an interval of 1 minute, on their right upper arm using an electronic blood pressure monitor (Omron HEM‐7430; Omron Corporation, Kyoto, Japan) after 5 minutes of rest in the seated position. The values of both the readings as well as their mean were recorded. If the difference between the 2 SBP measurements was \>10 mm Hg, a third blood pressure reading was taken and the mean SBP and DBP was calculated using the last 2 readings in such cases. The mean SBP and DBP were used for all calculations. Additionally, information was collected on any prescription drugs taken by the participants in the past 2 weeks for antiplatelet, blood pressure, lipid, or glucose control during an in‐person interview.

Since this study was done in a Chinese cohort, we used the Chinese Guidelines for the Management of Hypertension to define hypertension and classify patients with hypertension into different hypertension subtypes.[15](#jah34457-bib-0015){ref-type="ref"} Participants were considered to have hypertension if they had an average SBP of at least 140 mm Hg or an average DBP of at least 90 mm Hg or self‐reported use of an antihypertensive medication in the past 2 weeks. IDH was defined as an average SBP of \<140 mm Hg but a DBP of at least 90 mm Hg. We defined IDH based on the participant\'s SBP and DBP at the time of screening, and the IDH group included both untreated IDH participants and those with IDH despite antihypertensive medication. The "other hypertensive subtypes" group included all hypertensives, except those with IDH, including participants with isolated systolic hypertension (ISH; SBP ≥140 mm Hg and DBP \<90 mm Hg), combined systolic‐diastolic hypertension (SDH; SBP ≥140 mm Hg and DBP ≥90 mm Hg), and controlled hypertensives (participants who reported having a history of hypertension or taking antihypertensive medications but had an SBP \<140 mm Hg and a DBP \<90 mm Hg). Participants who did not have a history of hypertension or antihypertensive medication use and who had an SBP \<140 mm Hg and a DBP \<90 mm Hg were defined as normotensives.

Participants were considered to be aware of their hypertension if they responded "yes" to the question "Have you ever been diagnosed with hypertension?". Participants were considered to be receiving treatment for hypertension if they reported using antihypertensive medication (Western or traditional Chinese medication) currently or within the last 2 weeks.

Independent Variables {#jah34457-sec-0012}
---------------------

Information on the participants' sociodemographic characteristics, health behaviors, medical history, and cardiovascular risk factors was recorded during in‐person interviews as described previously.[22](#jah34457-bib-0022){ref-type="ref"} Height and weight were collected using standard protocols, and body mass index (BMI) was calculated by dividing the weight in kilograms by the square of height in meters. Obesity was defined as a BMI of at least 28 kg/m^2^, which was in accordance with the recommendations of the Working Group on Obesity in China.[24](#jah34457-bib-0024){ref-type="ref"}

We also formed diverse, mutually exclusive subgroups, to assess if some population subgroups had higher or lower rates of prevalence and awareness compared with the average rates of the total population. These subgroups were defined a priori by all possible combinations of 10 characteristics: age group (35--44, 45--54, 55--64, and 65--75 years), sex (men, women), geographic region (Western, Central, Eastern), urbanity (urban, rural), occupation (farmer, non‐farmer), annual household income (\<10 000, 10 000--50 000, and \>50 000 Yuan/year), education (primary school and below, middle school, high school, college and above), prior cardiovascular events (myocardial infarction or stroke; yes versus no), current smoker (yes versus no), and diabetes mellitus (yes versus no).

Statistical Analysis {#jah34457-sec-0013}
--------------------

We assessed the prevalence of IDH among the overall study population and among hypertensive participants (both overall and among untreated and treated hypertensives) and compared the prevalence of IDH with other hypertension subtypes across different age groups. We also calculated age‐ and sex‐standardized prevalence of IDH at the national level, standardizing against data from all 31 provinces in the 2010 Chinese Census. We then described the characteristics of participants with IDH and compared these with normotensive as well as with other hypertensive subgroups, and described the characteristics of untreated and treated participants with IDH separately. Next, we assessed the awareness of hypertension among untreated IDH participants across different population characteristics; and compared the awareness rates of untreated IDH participants with those of untreated ISH and SDH participants across different age groups. We assessed awareness only among untreated IDH participants as some treated participants with IDH may have adequately lowered their DBP and moved to the controlled hypertensive group, thus underestimating awareness rates among those having IDH despite treatment. The statistical significance of the differences between groups was assessed using Pearson Chi‐squared test.

We retained 1198 mutually exclusive subgroups of at least 200 participants each, which included 84.1% of the participants with IDH, and calculated the prevalence of IDH among all study participants and the awareness rates among untreated IDH participants. We also used histograms to show the rate distributions, and repeated the analysis by restricting to 731 subgroups containing at least 500 participants each (which included 77.6% of the participants with IDH).

Among participants who had IDH despite treatment, we assessed the number and class of medications reported by them. Medication usage was divided into 6 medication classes defined by the 2010 Chinese guidelines for the management of hypertension[15](#jah34457-bib-0015){ref-type="ref"} and included angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, beta‐blockers, calcium channel blockers, diuretics, and fixed‐dose combination drugs. We also collected information on the traditional Chinese medications (TCMs) used for hypertension. To assess whether the management of IDH patients varied by severity, we stratified them into 3 groups based on the degree DBP elevation (90--95, 96--100, and \>100 mm Hg) and compared the most frequently used antihypertensive medication class and the number of antihypertensive medications used by patients in each of these groups.

Finally, we developed 2 multivariable generalized linear mixed models with a logit link function and township‐specific random intercepts (to account for geographic autocorrelation) to identify individual characteristics associated with prevalence of IDH, and the awareness of hypertension among untreated IDH participants (details in Data [S1](#jah34457-sup-0001){ref-type="supplementary-material"}). For identifying the characteristics associated with IDH, we compared IDH participants with both normotensives as well as other hypertensives using 2 separate models. Explanatory variables included participants' age, sex, marital status, annual household income, education level, occupation, geographical region, health insurance status, smoking, alcohol use, obesity, physician‐diagnosed diabetes mellitus (DM), and prior cardiovascular events (myocardial infarction or stroke).

All analyses were conducted using R 3.33 (The R Foundation for Statistical Computing, Vienna, Austria) and SAS 9.4 (SAS Institute Inc, Cary, NC). The central ethics committee at the China National Center for Cardiovascular Disease and the Internal Review Board at Yale University approved this project, and written informed consent was obtained from all enrolled participants.

Results {#jah34457-sec-0014}
=======

Population Characteristics {#jah34457-sec-0015}
--------------------------

Our sample included 2 310 184 participants with a mean age of 55.7 (SD 9.8) years; 1 374 684 (59.5%) were women; and 1 023 780 (44.3%) had hypertension. Compared with the population aged 35 to 75 years in the 2010 Chinese Census, our sample contained more people from older age groups (70.4% of people with age 50 and older in the Million Persons Project versus 46.1% in Census).

Prevalence and Characteristics of Participants With IDH {#jah34457-sec-0016}
-------------------------------------------------------

Overall, 73 279 (3.2% of the study population and 7.2% of hypertensives) participants had IDH and 950 501 (41.1% of the study population) participants had other types of hypertension (including, 469 349 \[20.3%\] with ISH, 403 912 \[17.5%\] with SDH, and 77 240 \[3.3%\] with controlled hypertension). When we standardized our results to national census‐based estimates, we found a higher prevalence of IDH (3.8%) but a lower prevalence of other hypertension subgroups (34.0%). Overall, participants with IDH were more likely to be younger, men, employed, married, more educated, have higher income, consume alcohol, be current smoker, and obese than those who were normotensive or who had other types of hypertension (all *P*\<0.001; Table [1](#jah34457-tbl-0001){ref-type="table"}). Additionally, participants with IDH were more likely to have a history of myocardial infarction, stroke, and DM (0.7%, 2.2%, and 4.8% respectively) when compared with normotensive participants (0.5%, 1.2%, and 4.0% respectively), and less likely to have a history of myocardial infarction, stroke, and DM compared with participants with other types of hypertension (1.1%, 4.1%, and 9.8% respectively). Both untreated and treated IDH participants had similar characteristics (Table [S1](#jah34457-sup-0001){ref-type="supplementary-material"}).

###### 

Baseline Characteristics of Participants With Isolated Diastolic Hypertension Compared With Normotensives and Other Hypertensives

  Characteristics, n (%)                            Normotensives       Isolated Diastolic Hypertension   Other Hypertensives
  ------------------------------------------------- ------------------- --------------------------------- ---------------------
  n (%)                                             1 286 404 (55.7%)   73 279 (3.2%)                     950 501 (41.1%)
  Age, y                                                                                                  
  35 to 39                                          91 686 (7.1%)       4603 (6.3%)                       14 056 (1.5%)
  40 to 44                                          181 177 (14.1%)     10 538 (14.4%)                    45 006 (4.7%)
  45 to 49                                          229 912 (17.9%)     15 328 (20.9%)                    91 801 (9.7%)
  50 to 54                                          235 412 (18.3%)     16 479 (22.5%)                    149 641 (15.7%)
  55 to 59                                          170 190 (13.2%)     10 082 (13.8%)                    147 992 (15.6%)
  60 to 64                                          182 963 (14.2%)     8910 (12.2%)                      205 833 (21.7%)
  65 to 69                                          123 906 (9.6%)      4985 (6.8%)                       176 376 (18.6%)
  70 to 75                                          71 158 (5.5%)       2354 (3.2%)                       119 796 (12.6%)
  Sex                                                                                                     
  Men                                               501 100 (39.0%)     42 360 (57.8%)                    392 040 (41.2%)
  Women                                             785 304 (61.0%)     30 919 (42.2%)                    558 461 (58.8%)
  Urbanity                                                                                                
  Urban                                             517 420 (40.2%)     26 309 (35.9%)                    345 720 (36.4%)
  Rural                                             768 984 (59.8%)     46 970 (64.1%)                    604 781 (63.6%)
  Region                                                                                                  
  Eastern                                           416 104 (32.3%)     23 902 (32.6%)                    352 929 (37.1%)
  Western                                           494 433 (38.4%)     28 156 (38.4%)                    308 351 (32.4%)
  Central                                           375 867 (29.2%)     21 221 (29.0%)                    289 221 (30.4%)
  Education                                                                                               
  Primary school or lower                           512 301 (39.8%)     26 212 (35.8%)                    473 213 (49.8%)
  Middle school                                     432 275 (33.6%)     25 959 (35.4%)                    288 724 (30.4%)
  High school                                       211 349 (16.4%)     12 368 (16.9%)                    126 468 (13.3%)
  College or above                                  111 560 (8.7%)      7602 (10.4%)                      49 895 (5.2%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   18 919 (1.5%)       1138 (1.6%)                       12 201 (1.3%)
  Employment                                                                                              
  Employed                                          963 858 (74.9%)     57 582 (78.6%)                    649 247 (68.3%)
  Unemployed                                        17 294 (1.3%)       1345 (1.8%)                       11 630 (1.2%)
  Retired                                           185 763 (14.4%)     8342 (11.4%)                      191 626 (20.2%)
  Housework                                         95 722 (7.4%)       4470 (6.1%)                       83 403 (8.8%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   23 767 (1.8%)       1540 (2.1%)                       14 595 (1.5%)
  Occupation                                                                                              
  Farmer                                            602 369 (46.8%)     34 562 (47.2%)                    492 275 (51.8%)
  Non‐farmer                                        660 268 (51.3%)     37 177 (50.7%)                    443 631 (46.7%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   23 767 (1.8%)       1540 (2.1%)                       14 595 (1.5%)
  Household income, Yuan/y                                                                                
  \<10 000                                          256 630 (19.9%)     14 307 (19.5%)                    216 481 (22.8%)
  10 000 to 50 000                                  711 228 (55.3%)     40 359 (55.1%)                    521 951 (54.9%)
  \>50 000                                          199 441 (15.5%)     11 908 (16.3%)                    128 457 (13.5%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   119 105 (9.3%)      6705 (9.1%)                       83 612 (8.8%)
  Marital status                                                                                          
  Married                                           1 208 737 (94.0%)   69 159 (94.4%)                    869 211 (91.4%)
  Widowed, separated, divorced, single              61 396 (4.8%)       3192 (4.4%)                       70 389 (7.4%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   16 271 (1.3%)       928 (1.3%)                        10 901 (1.1%)
  Health insurance status                                                                                 
  Insured                                           1 258 190 (97.8%)   71 580 (97.7%)                    932 199 (98.1%)
  Uninsured                                         8388 (0.7%)         502 (0.7%)                        4890 (0.5%)
  Unknown[\*](#jah34457-note-0006){ref-type="fn"}   19 826 (1.5%)       1197 (1.6%)                       13 412 (1.4%)
  Medical history                                                                                         
  Myocardial infarction                             6281 (0.5%)         496 (0.7%)                        10 447 (1.1%)
  Stroke                                            15 628 (1.2%)       1614 (2.2%)                       38 626 (4.1%)
  Diabetes mellitus                                 51 410 (4.0%)       3499 (4.8%)                       93 329 (9.8%)
  Cardiovascular disease risk factor                                                                      
  Current smoker                                    249 422 (19.4%)     20 667 (28.2%)                    185 778 (19.5%)
  Current drinker                                   292 489 (22.7%)     26 529 (36.2%)                    240 183 (25.3%)
  Obesity                                           134 244 (10.4%)     17 241 (23.5%)                    214 058 (22.5%)

*P*‐value \<0.001 for all comparisons among the 3 groups.

Participants either refused to answer the question or did not know the answer.

The prevalence of IDH decreased with age, whereas the prevalence of other hypertension subtypes (including ISH, SDH and controlled hypertensives) increased with age (Figure [1](#jah34457-fig-0001){ref-type="fig"}). The prevalence of IDH was significantly higher for men (4.5% of overall population and 9.8% of hypertensives) as compared with women (2.2% of overall population and 5.2% of hypertensives; Table [2](#jah34457-tbl-0002){ref-type="table"}). The prevalence was also significantly higher among those living in rural areas and Western regions, who were at least college educated, and had a higher income (Table [2](#jah34457-tbl-0002){ref-type="table"}). Prevalence of IDH showed a similar distribution across different population subgroups in both treated and untreated hypertensive participants (Table [3](#jah34457-tbl-0003){ref-type="table"} and Table [S2](#jah34457-sup-0001){ref-type="supplementary-material"}).

![Prevalence of isolated diastolic hypertension and other types of hypertension (isolated systolic hypertension, systolic‐diastolic hypertension, and controlled hypertension), by age group.](JAH3-8-e012954-g001){#jah34457-fig-0001}

###### 

Prevalence of Isolated Diastolic Hypertension Among All Participants and Hypertensive Participants, by Population Characteristics

  Characteristics                                   All Participants   Hypertensive Participants               
  ------------------------------------------------- ------------------ --------------------------- ----------- ----------------------------
  n (%, 95% CI)                                     2 310 184          73 279 (3.2%, 3.1--3.2)     1 023 780   73 279 (7.2%, 7.1--7.2)
  Age, y                                                                                                       
  35 to 39                                          110 345            4603 (4.2%, 4.1--4.3)       18 659      4603 (24.7%, 24.1--25.3)
  40 to 44                                          236 721            10 538 (4.5%, 4.4--4.5)     55 544      10 538 (19.0%, 18.6--19.3)
  45 to 49                                          337 041            15 328 (4.5%, 4.5--4.6)     107 129     15 328 (14.3%, 14.1--14.5)
  50 to 54                                          401 532            16 479 (4.1%, 4.0--4.2)     166 120     16 479 (9.9%, 9.8--10.1)
  55 to 59                                          328 264            10 082 (3.1%, 3.0--3.1)     158 074     10 082 (6.4%, 6.3--6.5)
  60 to 64                                          397 706            8910 (2.2%, 2.2--2.3)       214 743     8910 (4.1%, 4.1--4.2)
  65 to 69                                          305 267            4985 (1.6%, 1.6--1.7)       181 361     4985 (2.7%, 2.7--2.8)
  70 to 75                                          193 308            2354 (1.2%, 1.2--1.3)       122 150     2354 (1.9%, 1.9--2.0)
  Sex                                                                                                          
  Men                                               935 500            42 360 (4.5%, 4.5--4.6)     434 400     42 360 (9.8%, 9.7--9.8)
  Women                                             1 374 684          30 919 (2.2%, 2.2--2.3)     589 380     30 919 (5.2%, 5.2--5.3)
  Urbanity                                                                                                     
  Urban                                             889 449            26 309 (3.0%, 2.9--3.0)     372 029     26 309 (7.1%, 7.0--7.2)
  Rural                                             1 420 735          46 970 (3.3%, 3.3--3.3)     651 751     46 970 (7.2%, 7.1--7.3)
  Region                                                                                                       
  Eastern                                           792 935            23 902 (3.0%, 3.0--3.1)     376 831     23 902 (6.3%, 6.3--6.4)
  Western                                           830 940            28 156 (3.4%, 3.3--3.4)     336 507     28 156 (8.4%, 8.3--8.5)
  Central                                           686 309            21 221 (3.1%, 3.1--3.1)     310 442     21 221 (6.8%, 6.7--6.9)
  Education                                                                                                    
  Primary school or lower                           1 011 726          26 212 (2.6%, 2.6--2.6)     499 425     26 212 (5.2%, 5.2--5.3)
  Middle school                                     746 958            25 959 (3.5%, 3.4--3.5)     314 683     25 959 (8.2%, 8.2--8.3)
  High school                                       350 185            12 368 (3.5%, 3.5--3.6)     138 836     12 368 (8.9%, 8.8--9.1)
  College or above                                  169 057            7602 (4.5%, 4.4--4.6)       57 497      7602 (13.2%, 12.9--13.5)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   32 258             1138 (3.5%, 3.3--3.7)       13 339      1138 (8.5%, 8.1--9.0)
  Employment                                                                                                   
  Employed                                          1 670 687          57 582 (3.4%, 3.4--3.5)     706 829     57 582 (8.1%, 8.1--8.2)
  Unemployed                                        30 269             1345 (4.4%, 4.2--4.7)       12 975      1345 (10.4%, 9.8--10.9)
  Retired                                           385 731            8342 (2.2%, 2.1--2.2)       199 968     8342 (4.2%, 4.1--4.3)
  Housework                                         183 595            4470 (2.4%, 2.4--2.5)       87 873      4470 (5.1%, 4.9--5.2)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   39 902             1540 (3.9%, 3.7--4.0)       16 135      1540 (9.5%, 9.1--10.0)
  Occupation                                                                                                   
  Farmer                                            1 129 206          34 562 (3.1%, 3.0--3.1)     526 837     34 562 (6.6%, 6.5--6.6)
  Non‐farmer                                        1 141 076          37 177 (3.3%, 3.2--3.3)     480 808     37 177 (7.7%, 7.7--7.8)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   39 902             1540 (3.9%, 3.7--4.0)       16 135      1540 (9.5%, 9.1--10.0)
  Household income, Yuan/y                                                                                     
  \<10 000                                          487 418            14 307 (2.9%, 2.9--3.0)     230 788     14 307 (6.2%, 6.1--6.3)
  10 000 to 50 000                                  1 273 538          40 359 (3.2%, 3.1--3.2)     562 310     40 359 (7.2%, 7.1--7.2)
  \>50 000                                          339 806            11 908 (3.5%, 3.4--3.6)     140 365     11 908 (8.5%, 8.3--8.6)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   209 422            6705 (3.2%, 3.1--3.3)       90 317      6705 (7.4%, 7.3--7.6)
  Marital status                                                                                               
  Married                                           2 147 107          69 159 (3.2%, 3.2--3.2)     938 370     69 159 (7.4%, 7.3--7.4)
  Widowed, separated, divorced, single              134 977            3192 (2.4%, 2.3--2.4)       73 581      3192 (4.3%, 4.2--4.5)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   28 100             928 (3.3%, 3.1--3.5)        11 829      928 (7.8%, 7.4--8.3)
  Health insurance status                                                                                      
  Insured                                           2 261 969          71 580 (3.2%, 3.1--3.2)     1 003 779   71 580 (7.1%, 7.1--7.2)
  Uninsured                                         13 780             502 (3.6%, 3.3--4.0)        5392        502 (9.3%, 8.5--10.1)
  Unknown[\*](#jah34457-note-0008){ref-type="fn"}   34 435             1197 (3.5%, 3.3--3.7)       14 609      1197 (8.2%, 7.7--8.6)
  Medical history                                                                                              
  Myocardial infarction                             17 224             496 (2.9%, 2.6--3.1)        10 943      496 (4.5%, 4.1--4.9)
  Stroke                                            55 868             1614 (2.9%, 2.8--3.0)       40 240      1614 (4.0%, 3.8--4.2)
  Diabetes mellitus                                 148 238            3499 (2.4%, 2.3--2.4)       96 828      3499 (3.6%, 3.5--3.7)
  CVD risk factor                                                                                              
  Current smoker                                    455 867            20 667 (4.5%, 4.5--4.6)     206 445     20 667 (10.0%, 9.9--10.1)
  Current drinker                                   559 201            26 529 (4.7%, 4.7--4.8)     266 712     26 529 (9.9%, 9.8--10.1)
  Obesity                                           365 543            17 241 (4.7%, 4.6--4.8)     231 299     17 241 (7.5%, 7.3--7.6)

CVD indicates cardiovascular disease; IDH, isolated diastolic hypertension.

Participants either refused to answer the question or did not know the answer.

###### 

Prevalence and Awareness of Isolated Diastolic Hypertension Among Untreated Hypertensives, by Population Characteristics

  Characteristics                                   Untreated Hypertensive Participants (n)   Prevalence of IDH n (%, 95% CI)   Awareness Among IDH Participants n (%, 95% CI)
  ------------------------------------------------- ----------------------------------------- --------------------------------- ------------------------------------------------
  n (%, 95% CI)                                     718 666                                   63 112 (8.8%, 8.7--8.8)           6512 (10.3%, 10.1--10.6)
  Age, y                                                                                                                        
  35 to 39                                          16 425                                    4361 (26.6%, 25.9--27.2)          274 (6.3%, 5.6--7.0)
  40 to 44                                          46 923                                    9658 (20.6%, 20.2--20.9)          633 (6.6%, 6.1--7.0)
  45 to 49                                          84 788                                    13 560 (16.0%, 15.7--16.2)        1179 (8.7%, 8.2--9.2)
  50 to 54                                          121 131                                   13 939 (11.5%, 11.3--11.7)        1551 (11.1%, 10.6--11.6)
  55 to 59                                          109 324                                   8354 (7.6%, 7.5--7.8)             1022 (12.2%, 11.5--12.9)
  60 to 64                                          144 370                                   7258 (5.0%, 4.9--5.1)             969 (13.4%, 12.6--14.1)
  65 to 69                                          117 786                                   4062 (3.4%, 3.3--3.6)             619 (15.2%, 14.1--16.3)
  70 to 75                                          77 919                                    1920 (2.5%, 2.4--2.6)             265 (13.8%, 12.3--15.3)
  Sex                                                                                                                           
  Men                                               311 796                                   36 421 (11.7%, 11.6--11.8)        3777 (10.4%, 10.1--10.7)
  Women                                             406 870                                   26 691 (6.6%, 6.5--6.6)           2735 (10.2%, 9.9--10.6)
  Urbanity                                                                                                                      
  Urban                                             250 233                                   22 345 (8.9%, 8.8--9.0)           2187 (9.8%, 9.4--10.2)
  Rural                                             468 433                                   40 767 (8.7%, 8.6--8.8)           4325 (10.6%, 10.3--10.9)
  Region                                                                                                                        
  Eastern                                           259 305                                   20 374 (7.9%, 7.8--8.0)           2432 (11.9%, 11.5--12.4)
  Western                                           240 487                                   24 697 (10.3%, 10.1--10.4)        1998 (8.1%, 7.7--8.4)
  Central                                           218 874                                   18 041 (8.2%, 8.1--8.4)           2082 (11.5%, 11.1--12.0)
  Education                                                                                                                     
  Primary school or lower                           357 641                                   23 063 (6.4%, 6.4--6.5)           2450 (10.6%, 10.2--11.0)
  Middle school                                     220 050                                   22 377 (10.2%, 10.0--10.3)        2292 (10.2%, 9.8--10.6)
  High school                                       92 551                                    10 333 (11.2%, 11.0--11.4)        1035 (10.0%, 9.4--10.6)
  College or above                                  38 218                                    6314 (16.5%, 16.1--16.9)          673 (10.7%, 9.9--11.4)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   10 206                                    1025 (10.0%, 9.5--10.6)           62 (6.0%, 4.6--7.5)
  Employment                                                                                                                    
  Employed                                          522 751                                   50 534 (9.7%, 9.6--9.7)           4909 (9.7%, 9.5--10.0)
  Unemployed                                        8739                                      1109 (12.7%, 12.0--13.4)          147 (13.3%, 11.3--15.3)
  Retired                                           116 143                                   6351 (5.5%, 5.3--5.6)             897 (14.1%, 13.3--15.0)
  Housework                                         58 954                                    3761 (6.4%, 6.2--6.6)             441 (11.7%, 10.7--12.8)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   12 079                                    1357 (11.2%, 10.7--11.8)          118 (8.7%, 7.2--10.2)
  Occupation                                                                                                                    
  Famer                                             387 791                                   30 616 (7.9%, 7.8--8.0)           3040 (9.9%, 9.6--10.3)
  Non‐farmer                                        318 796                                   31 139 (9.8%, 9.7--9.9)           3354 (10.8%, 10.4--11.1)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   12 079                                    1357 (11.2%, 10.7--11.8)          118 (8.7%, 7.2--10.2)
  Household income, Yuan/y                                                                                                      
  \<10 000                                          168 343                                   12 725 (7.6%, 7.4--7.7)           1222 (9.6%, 9.1--10.1)
  10 000 to 50 000                                  390 550                                   34 601 (8.9%, 8.8--8.9)           3462 (10.0%, 9.7--10.3)
  \>50 000                                          92 258                                    9903 (10.7%, 10.5--10.9)          1186 (12.0%, 11.3--12.6)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   67 515                                    5883 (8.7%, 8.5--8.9)             642 (10.9%, 10.1--11.7)
  Marital status                                                                                                                
  Married                                           662 083                                   59 671 (9.0%, 8.9--9.1)           6141 (10.3%, 10.0--10.5)
  Widowed, separated, divorced, single              47 873                                    2629 (5.5%, 5.3--5.7)             321 (12.2%, 11.0--13.5)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   8710                                      812 (9.3%, 8.7--9.9)              50 (6.2%, 4.5--7.8)
  Health insurance status                                                                                                       
  Insured                                           704 139                                   61 637 (8.8%, 8.7--8.8)           6371 (10.3%, 10.1--10.6)
  Uninsured                                         4130                                      448 (10.8%, 9.9--11.8)            48 (10.7%, 7.9--13.6)
  Unknown[\*](#jah34457-note-0010){ref-type="fn"}   10 397                                    1027 (9.9%, 9.3--10.5)            93 (9.1%, 7.3--10.8)
  Medical history                                                                                                               
  Myocardial infarction                             5167                                      334 (6.5%, 5.8--7.1)              99 (29.6%, 24.7--34.5)
  Stroke                                            18 897                                    986 (5.2%, 4.9--5.5)              309 (31.3%, 28.4--34.2)
  Diabetes mellitus                                 51 296                                    2521 (4.9%, 4.7--5.1)             650 (25.8%, 24.1--27.5)
  CVD risk factor                                                                                                               
  Current smoker                                    149 972                                   17 842 (11.9%, 11.7--12.1)        1847 (10.4%, 9.9--10.8)
  Current drinker                                   193 777                                   22 740 (11.7%, 11.6--11.9)        2389 (10.5%, 10.1--10.9)
  Obesity                                           146 456                                   13 970 (9.5%, 9.4--9.7)           1908 (13.7%, 13.1--14.2)

CVD indicates cardiovascular disease; IDH, isolated diastolic hypertension.

Participants either refused to answer the question or did not know the answer.

The 1198 subgroups varied with respect to the prevalence of participants with IDH (median: 2.9%, \[IQR: 1.7--4.7\]; Figure [S2](#jah34457-sup-0001){ref-type="supplementary-material"}). The prevalence of IDH was substantially higher in subgroups with participants who were younger, men, without prior cardiovascular event, and without DM as compared with participants who were older, women, with prior cardiovascular event, and with DM (Figure [2](#jah34457-fig-0002){ref-type="fig"}). Subgroups with at least 500 participants had similar results (Figures [S3](#jah34457-sup-0001){ref-type="supplementary-material"} and [S4](#jah34457-sup-0001){ref-type="supplementary-material"}).

![Density plots of prevalence of isolated diastolic hypertension among all study participants in 1198 mutually exclusive population subgroups (of at least 200 participants), by age, sex, prior cardiovascular events, history of diabetes mellitus, and urbanity.](JAH3-8-e012954-g002){#jah34457-fig-0002}

In mixed effects multivariable logistic regression analysis assessing independent predictors of IDH, we identified several individual characteristics associated with the prevalence of IDH (Table [4](#jah34457-tbl-0004){ref-type="table"}). When compared with normotensives, participants who were young‐ and middle‐aged, men, were at least college educated, consumed alcohol, had DM, were obese, and had prior cardiovascular events were more likely to have IDH than those who were older, women, less educated, did not consume alcohol, were not obese, and did not have DM or prior cardiovascular events (all *P*\<0.01). Participants who were married, farmers, and current smokers were less likely to have IDH (all *P*\<0.001). Income and health insurance did not have a significant association with prevalence of IDH. Similarly, when compared with participants with other hypertension subtypes, participants who were younger, men, were at least college educated, and consumed alcohol were more likely to have IDH (all *P*\<0.001); whereas, participants who were older, farmer, current smokers, had DM, were obese, had prior cardiovascular events, and belonged to the Central or Eastern regions were more likely to have other types of hypertension (all *P*\<0.001).

###### 

Mixed Effects Multivariable Regression Models for Association Between Individual Characteristics and the Prevalence of Isolated Diastolic Hypertension and the Awareness Among Untreated Participants With Isolated Diastolic Hypertension

                             Prevalence of IDH   Awareness Among IDH Participants                                                     
  -------------------------- ------------------- ---------------------------------- ------------------- --------- ------------------- ---------
  Age, y                                                                                                                              
  35 to 39                   1                                                      1                             1                   
  40 to 44                   1.27 (1.22--1.32)   \<0.001                            0.81 (0.78--0.84)   \<0.001   1.24 (1.08--1.43)   0.003
  45 to 49                   1.46 (1.41--1.52)   \<0.001                            0.59 (0.57--0.62)   \<0.001   1.65 (1.45--1.88)   \<0.001
  50 to 54                   1.54 (1.48--1.60)   \<0.001                            0.40 (0.38--0.42)   \<0.001   2.13 (1.87--2.43)   \<0.001
  55 to 59                   1.29 (1.25--1.35)   \<0.001                            0.25 (0.24--0.26)   \<0.001   2.37 (2.07--2.72)   \<0.001
  60 to 64                   0.99 (0.95--1.03)   0.534                              0.15 (0.14--0.15)   \<0.001   2.75 (2.40--3.17)   \<0.001
  65 to 69                   0.79 (0.75--0.83)   \<0.001                            0.09 (0.09--0.10)   \<0.001   3.26 (2.80--3.79)   \<0.001
  70 to 75                   0.64 (0.61--0.68)   \<0.001                            0.06 (0.06--0.07)   \<0.001   3.05 (2.53--3.68)   \<0.001
  Sex                                                                                                                                 
  Men                        1                                                      1                             1                   
  Women                      0.45 (0.44--0.45)   \<0.001                            0.50 (0.49--0.51)   \<0.001   1.07 (1.00--1.14)   0.052
  Marital status                                                                                                                      
  Not married                1                                                      1                             1                   
  Married                    0.91 (0.88--0.95)   \<0.001                            1.02 (0.98--1.07)   0.279     0.88 (0.78--1.00)   0.057
  Household income, Yuan/y                                                                                                            
  \<10 000                   1                                                      1                             1                   
  10 000 to 50 000           0.97 (0.95--1.00)   0.031                              1.01 (0.99--1.04)   0.277     1.04 (0.97--1.13)   0.264
  \>50 000                   0.99 (0.95--1.02)   0.417                              1.05 (1.01--1.08)   0.014     1.17 (1.06--1.30)   0.003
  Education level                                                                                                                     
  Lower than college         1                                                      1                             1                   
  College or above           1.08 (1.04--1.11)   \<0.001                            1.10 (1.07--1.14)   \<0.001   1.16 (1.05--1.28)   0.003
  Occupation                                                                                                                          
  Not farmer                 1                                                      1                             1                   
  Farmer                     0.95 (0.92--0.97)   \<0.001                            0.92 (0.89--0.94)   \<0.001   0.94 (0.87--1.00)   0.066
  Health insurance status                                                                                                             
  Uninsured                  1                                                      1                             1                   
  Insured                    1.07 (0.98--1.15)   0.115                              1.02 (0.94--1.10)   0.699     0.87 (0.69--1.10)   0.259
  CVD risk factor                                                                                                                     
  Current smoker             0.88 (0.86--0.90)   \<0.001                            0.96 (0.94--0.99)   0.001     1.02 (0.95--1.09)   0.656
  Current drinker            1.38 (1.35--1.41)   \<0.001                            1.07 (1.04--1.09)   \<0.001   1.02 (0.96--1.09)   0.529
  Diabetes mellitus          1.05 (1.01--1.09)   0.012                              0.63 (0.60--0.65)   \<0.001   2.31 (2.09--2.55)   \<0.001
  Obesity                    2.49 (2.44--2.54)   \<0.001                            0.92 (0.90--0.94)   \<0.001   1.50 (1.41--1.59)   \<0.001
  Prior CVE                  1.65 (1.57--1.74)   \<0.001                            0.80 (0.76--0.84)   \<0.001   3.14 (2.75--3.59)   \<0.001
  Geographic region                                                                                                                   
  Western                    1                                                      1                             1                   
  Eastern                    0.91 (0.88--0.95)   \<0.001                            0.78 (0.75--0.81)   \<0.001   1.52 (1.38--1.67)   \<0.001
  Central                    0.97 (0.93--1.01)   0.167                              0.82 (0.79--0.86)   \<0.001   1.43 (1.30--1.58)   \<0.001

Model 1 includes normotensive participants and participants with isolated diastolic hypertension. Model 2 includes participants with isolated diastolic hypertension and participants with other types of hypertension (isolated systolic hypertension, systolic diastolic hypertension, controlled hypertension). CVD indicates cardiovascular disease; CVE, cardiovascular event; IDH, isolated diastolic hypertension; ISH, isolated systolic hypertension; SDH, systolic diastolic hypertension.

Awareness of Having Hypertension Among Untreated Participants {#jah34457-sec-0017}
-------------------------------------------------------------

Among untreated IDH participants (n=63 112 or 86.1% of the overall IDH group), only 6512 (or 10.3%) were aware of having hypertension, whereas 72 220 (or 24.8%) of the 290 645 untreated ISH and 89 516 (or 44.1%) of the 203 173 untreated SDH participants were aware of having hypertension. Awareness among untreated participants across all subtypes of hypertension increased with age; however, awareness among participants with IDH was significantly lower than other hypertensives (ISH and SDH), across all age groups (Figure [3](#jah34457-fig-0003){ref-type="fig"}; *P*\<0.005 for all age ‐groups). The awareness rates were higher among those who lived in rural areas or Eastern or Central regions, were retired, had a higher income, and were widowed/separated/or divorced (Table [3](#jah34457-tbl-0003){ref-type="table"}). Fewer than 15% of the IDH participants with at least 1 or more cardiovascular risk factors (including smoking, alcohol use, and obesity) and \<33% of IDH participants with a prior cardiovascular event or DM were aware of having hypertension. The 1198 subgroups varied with respect to awareness of having hypertension among untreated IDH participants (median: 9.7% \[IQR: 4.0--17.6\]; Figure [S2](#jah34457-sup-0001){ref-type="supplementary-material"}). Awareness was higher in subgroups of participants who were older, had prior cardiovascular event, and had prior DM (Figure [4](#jah34457-fig-0004){ref-type="fig"}). Awareness rates were similar among men and women and in rural and urban areas. Subgroups with at least 500 participants had similar results (Figures [S3](#jah34457-sup-0001){ref-type="supplementary-material"} and [S4](#jah34457-sup-0001){ref-type="supplementary-material"}).

![Awareness of having hypertension among untreated participants with isolated diastolic hypertension (IDH), isolated systolic hypertension (ISH), and systolic‐diastolic hypertension (SDH), by age group.](JAH3-8-e012954-g003){#jah34457-fig-0003}

![Density plots of awareness of having hypertension among untreated participants with isolated diastolic hypertension in 1198 mutually exclusive population subgroups (of at least 200 participants), by age, sex, prior cardiovascular events, history of diabetes mellitus, and urbanity.](JAH3-8-e012954-g004){#jah34457-fig-0004}

We identified several independent factors associated with awareness of having hypertension among untreated IDH participants (Table [4](#jah34457-tbl-0004){ref-type="table"}). Awareness was significantly higher among IDH participants who were older, women, had higher income (\>50 000 Yuan/year), were at least college educated, obese, had DM, prior cardiovascular event, and belonged to Central or Eastern region (all *P*\<0.05). Participant\'s marital status, occupation, health insurance status, and health behaviors like smoking and alcohol use, were not independently associated with their awareness of having hypertension.

Treatment Patterns Among Treated Participants With IDH {#jah34457-sec-0018}
------------------------------------------------------

Most treated participants with IDH reported taking 1 antihypertensive medication in both urban and rural areas (Figure [5](#jah34457-fig-0005){ref-type="fig"}). Even though use of combination therapy increased slightly with age, \<5% of the participants received ≥3 drugs across all age groups. Most treated participants with IDH reported taking Western antihypertensive medications (9969 or 98%). Among IDH participants using 2 or fewer classes of medications, calcium channel blockers (42%) were the most frequent class of medication used, followed by angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers (20%), and diuretics (7%), respectively (Table [5](#jah34457-tbl-0005){ref-type="table"}). On stratification of IDH patients based on their degree of DBP elevation, we found that the majority (74.7%) had DBP of 90 to 95 mm Hg, followed by 96 to 100 mm Hg (19.6%), and \>100 mm Hg (5.7%), respectively. The most frequently used antihypertensive medication class and the number of antihypertensive medications used did not vary significantly between 3 groups (both *P*\>0.05; Figure [S5](#jah34457-sup-0001){ref-type="supplementary-material"}).

![Number of antihypertensive medications used by treated participants with isolated diastolic hypertension, by age and urbanity.](JAH3-8-e012954-g005){#jah34457-fig-0005}

###### 

Classes of Antihypertensive Medications Used by Treated Participants With Isolated Diastolic Hypertension

      A               B             C               D             F             T
  --- --------------- ------------- --------------- ------------- ------------- -------------
  A   1808 (20.08%)   136 (1.51%)   602 (6.69%)     276 (3.07%)   10 (0.11%)    4 (0.04%)
  B                   331 (3.68%)   224 (2.49%)     27 (0.30%)    13 (0.14%)    3 (0.03%)
  C                                 3780 (41.99%)   71 (0.79%)    43 (0.48%)    14 (0.16%)
  D                                                 638 (7.09%)   11 (0.12%)    0 (0%)
  F                                                               563 (6.25%)   1 (0.01%)
  T                                                                             198 (2.20%)

A indicates angiotensin converting enzyme inhibitors or angiotensin receptor blockers; B, beta‐blockers; C, calcium channel blockers; D, diuretics; F, fixed‐dose combination drugs; T, traditional Chinese medication.

Discussion {#jah34457-sec-0019}
==========

In this large study, we report the characteristics, prevalence, awareness, and treatment patterns of people with IDH in China, and how these differ from other hypertensives and vary across diverse population subgroups. We found that IDH affected almost 4% of adults between 35 and 75 years in China (and represents nearly 25% of the hypertensive population aged \<45 years). Awareness of hypertension was significantly lower among people with IDH as compared with other types of hypertension and was lowest among young‐ and middle‐aged adults in whom IDH was most prevalent. Additionally, among those with IDH despite treatment, the vast majority were treated with only 1 class of antihypertensive medication.

This study extends the scientific literature in several ways. First, this is one of the largest population‐based studies, to our knowledge, to evaluate the characteristics and prevalence of IDH, allowing us to draw robust conclusions across a wide variety of diverse subgroups. Our findings that young age, male sex, obesity, DM, alcohol consumption, and prior cardiovascular events are positively associated with IDH prevalence supports and expands on the associations previously described in the literature but with smaller numbers of patients with IDH.[1](#jah34457-bib-0001){ref-type="ref"}, [3](#jah34457-bib-0003){ref-type="ref"}, [20](#jah34457-bib-0020){ref-type="ref"}, [25](#jah34457-bib-0025){ref-type="ref"}, [26](#jah34457-bib-0026){ref-type="ref"}, [27](#jah34457-bib-0027){ref-type="ref"} For example, Franklin et al[20](#jah34457-bib-0020){ref-type="ref"} and Liu et al[25](#jah34457-bib-0025){ref-type="ref"} showed that younger age, male sex, and BMI were predictors of IDH in a small population of IDH patients. In this study, we identified additional factors associated with IDH including DM, alcohol consumption, history of prior cardiovascular event, and showed that these associations were consistent across tens of thousands of individuals with IDH and across diverse population subgroups. The prevalence rates of IDH found in our study were also comparable with those reported previously in studies not only from Chinese cohorts (for example, Huang et al[3](#jah34457-bib-0003){ref-type="ref"} found a prevalence of 4.4% among adults aged 35 to 74 and Sun et al[11](#jah34457-bib-0011){ref-type="ref"} found a prevalence of 5.8% among adults \>35 years), but also from other low‐ and middle‐income countries.[26](#jah34457-bib-0026){ref-type="ref"}, [27](#jah34457-bib-0027){ref-type="ref"}

Second, to the best of our knowledge, our study is the first to assess the awareness of having hypertension among a large Chinese population with IDH compared with other hypertension subtypes, and to identify characteristics that are associated with awareness. Our findings suggest that even though awareness among participants with IDH increases with age, it is significantly lower as compared with awareness among participants with other hypertension subtypes, across all age groups. These findings are consistent with previous reports from other countries which have shown 26% lower diagnosis (hazard ratio 0.74; CI 0.60--0.92) and 31% lower medication initiation (hazard ratio 0.69; CI 0.55--0.86) among younger patients with IDH as compared with systolic/diastolic hypertension.[18](#jah34457-bib-0018){ref-type="ref"}

Third, our assessment of the antihypertensive medications among treated participants with IDH provides information on what medications may not be effectively treating IDH or that people are not taking. We found that the majority of these patients were treated with only 1 class of antihypertensive medication. Calcium channel blockers was the most frequently used class of antihypertensive medication among these patients, even though they may not be most effective for this phenotype, which could be due to the prescription habits of the physicians, availability, and cost‐related factors of other classes of antihypertensive medications.[28](#jah34457-bib-0028){ref-type="ref"}

Clinical Implications {#jah34457-sec-0020}
---------------------

These findings have important clinical implications as IDH is independently associated with a higher risk of incident heart failure and cardiovascular mortality as compared with normal BP, and BP lowering in patients with IDH has been shown to protect against major vascular events.[29](#jah34457-bib-0029){ref-type="ref"}, [30](#jah34457-bib-0030){ref-type="ref"}, [31](#jah34457-bib-0031){ref-type="ref"} As such, identifying characteristics that may be associated with IDH and understanding the current awareness and treatment patterns among those with IDH can help identify the patients at increased cardiovascular risk and highlight the opportunities for improving their care. Current hypertension management guidelines[15](#jah34457-bib-0015){ref-type="ref"}, [16](#jah34457-bib-0016){ref-type="ref"}, [17](#jah34457-bib-0017){ref-type="ref"} lack guidance on management of patients with IDH and the recent randomized clinical trials[32](#jah34457-bib-0032){ref-type="ref"}, [33](#jah34457-bib-0033){ref-type="ref"} focused only on SBP targets for improving outcomes, resulting in lack of contemporary guidance on optimal DBP targets for management of patients with IDH. As clinicians and public health professionals develop and implement strategies to help prevent and control hypertension, our findings suggest the need to target people with IDH among other hypertension subtypes for reducing the burden of hypertension.

Considering that patients with IDH are much younger and often without additional cardiovascular risk factors as compared with other hypertension subtypes, they are less likely to come in contact with the health system and hence, more likely to not to be diagnosed. These patients could benefit from more targeted hypertension screening initiatives focusing on the young‐ and middle‐aged adults. For example, promoting free BP screenings at work places and in schools and colleges could result in early diagnosis of those with IDH, and prevent the catastrophic sequelae of hypertension in these patients. Additionally, given the growing burden of obesity in China and its strong association with IDH, it is critical to slow the increase in BMI through public health interventions, to prevent the development of IDH in unaffected individuals. Moreover, increasing awareness of the clinical significance of an elevated DBP in the young and providing clear guidance on management of patients with IDH could also ensure better management of these patients. The point is that the emphasis on SBP should not lead to the neglect of people with IDH.

This study was derived from a large Chinese population. China is of special interest because it represents 25% of the world\'s population and hypertension is a major public health challenge in China. However, given that China is more recent in the epidemiological transition, and treatment rates are much lower than many Western countries, similar large‐scale studies in other countries are warranted to understand impact of nation‐specific characteristics on the epidemiology of IDH. Nevertheless, these findings are relevant for several low‐ and middle‐income countries where hypertension is growing in importance, treatment rates tend to be lower, and fewer evidence exists to guide public health programs.

Limitations {#jah34457-sec-0021}
-----------

Our study has several potential limitations. First, for estimation of characteristics and prevalence of participants with IDH, we classified patients into different hypertension subgroups based on the value of the SBP and DBP at enrollment, irrespective of their medication use. As such, some treated hypertensive participants may have had their SBP controlled with medication, and may have been included in the IDH group. However, the vast majority (86%) of the participants in the IDH group were untreated. Moreover, since the treated participants with IDH had persistent elevation of their DBP even after treatment, they were not much different from the untreated IDH group, as shown in Table [S1](#jah34457-sup-0001){ref-type="supplementary-material"}. Second, treated IDH patients who had their DBP \<90 mm Hg were classified as having "controlled hypertension" instead of IDH, which could have underestimated the prevalence of IDH of China. However, considering that less than one third of the people with hypertension receive treatment in China and an even fewer proportion actually have controlled hypertension, and that these rates are even lower for younger age groups where IDH is most prevalent,[23](#jah34457-bib-0023){ref-type="ref"} few individuals in the IDH group would have been classified as having "controlled hypertension". Third, our study used convenience rather than a nationally representative sample for large‐scale recruitment. This could have resulted in a sampling bias resulting in overestimation of the awareness and treatment rates since these participants would be more likely to be in contact with the health system. Fourth, awareness and treatment rates could also have been affected by a participant\'s access to and use of healthcare services, however, we did not collect this information in this study. Fifth, since we also used "self‐reported use of an antihypertensive medication in the past 2 weeks" as a criterion for defining hypertension, some patients taking hypertensive medication might not have reported that use, possibly underestimating the burden of hypertension in China. Lastly, for individuals who were aware of having hypertension, our study did not collect information on the duration of hypertension, which could have influenced the treatment patterns seen among these participants.

Conclusions {#jah34457-sec-0022}
===========

IDH affects a large number of adults in China, and these patients may have some unique characteristics as compared with people without hypertension as well as those with other types of hypertension. However, patients with IDH have the lowest rate of awareness compared with other hypertension subtypes, and most participants with IDH despite treatment had scope for further increase in the intensity of therapy. Our findings suggest the need to specifically focus public health and clinical strategies on people with IDH and improve their diagnosis and treatment, to mitigate the burden of hypertension, especially in the young‐ and middle‐aged population.
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**Table S2.** Prevalence of Isolated Diastolic Hypertension Among Treated Hypertensive Participants, by Population Characteristics

**Figure S1.** Flowchart of study participant selection in China Patient‐Centered Evaluative Assessment of Cardiac Events Million Persons Project.

**Figure S2.** Histograms of prevalence of isolated diastolic hypertension (IDH) and awareness among untreated IDH participants in 1198 mutually exclusive population subgroups (at least 200 participants each) defined priori by 10 selected characteristics.

**Figure S3.** Histograms prevalence of isolated diastolic hypertension (IDH) and awareness among untreated IDH participants in 731 mutually exclusive population subgroups (at least 500 participants each) defined priori by 10 selected characteristics.

**Figure S4.** Density plots of prevalence of isolated diastolic hypertension (IDH) among all study participants (**A**) and awareness among untreated IDH participants (**B**) in 731 mutually exclusive population subgroups (of at least 500 participants), by age, sex, prior cardiovascular events, history of diabetes mellitus, and urbanity.

**Figure S5.** Number of antihypertensive medications used by treated participants with isolated diastolic hypertension, by degree of diastolic blood pressure elevation.
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